NCT06211881 2024-01-18Chi-GVM Regimen for the Treatment of R/R PTCLThe First Affiliated Hospital with Nanjing Medical UniversityPhase NA Unknown50 enrolled
NCT03947242 2019-05-15Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer.Henan Cancer HospitalPhase NA Unknown48 enrolled